Intellia Therapeutics
NTLA
NTLA
348 hedge funds and large institutions have $4.69B invested in Intellia Therapeutics in 2022 Q1 according to their latest regulatory filings, with 61 funds opening new positions, 96 increasing their positions, 125 reducing their positions, and 77 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less first-time investments, than exits
New positions opened: | Existing positions closed:
23% less repeat investments, than reductions
Existing positions increased: 96 | Existing positions reduced: 125
33% less funds holding in top 10
Funds holding in top 10: 9 → 6 (-3)
38% less capital invested
Capital invested by funds: $7.59B → $4.69B (-$2.9B)
Holders
348
Holding in Top 10
6
Calls
$44.3M
Puts
$51.9M
Top Buyers
| 1 | +$90.2M | |
| 2 | +$75.3M | |
| 3 | +$47.1M | |
| 4 |
Millennium Management
New York
|
+$41.5M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$33M |
Top Sellers
| 1 | -$91.7M | |
| 2 | -$71.6M | |
| 3 | -$61.5M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$49.5M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$46.3M |